300206.SZ
理邦仪器
SZSE · Healthcare · C 制造业 · CN
CNY 11.93
−1.65%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.1B | 2.0B | 1.8B | 1.9B | 1.7B |
| Cost of Revenue | 872.0M | 832.5M | 771.9M | 826.8M | 762.3M |
| Gross Profit | 1.2B | 1.2B | 1.1B | 1.1B | 980.1M |
| Operating Expenses | |||||
| R&D Expense | 292.7M | 301.8M | 340.2M | 347.4M | 297.5M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 141.8M | 141.8M | 120.8M | 116.0M | 115.7M |
| Selling & Marketing Expense | 416.9M | 417.1M | 454.0M | 474.0M | 377.3M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 877.7M | 871.4M | 919.8M | 943.9M | 787.7M |
| Cost and Expenses | 1.7B | 1.7B | 1.7B | 1.8B | 1.5B |
| Operating Income (EBIT) | 363.4M | 314.0M | 164.8M | 214.2M | 242.7M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 366.2M | 316.2M | 165.9M | 221.4M | 243.8M |
| Income Tax Expense | 17.2M | 8.2M | 3.1M | (127.6K) | 11.2M |
| Bottom Line | |||||
| Net Income | 345.6M | 305.6M | 162.1M | 221.3M | 232.9M |
| Earnings from Cont. Ops | 349.0M | 308.0M | 162.8M | 221.6M | 232.6M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 345.6M | 305.6M | 162.1M | 221.3M | 232.9M |
| Per Share | |||||
| Basic EPS | CN¥0.60 | CN¥0.53 | CN¥0.28 | CN¥0.38 | CN¥0.40 |
| Diluted EPS | CN¥0.60 | CN¥0.53 | CN¥0.28 | CN¥0.38 | CN¥0.40 |
| Revenue Per Share | CN¥3.61 | CN¥3.45 | CN¥3.16 | CN¥3.34 | CN¥3.01 |
| Shares | |||||
| Basic Shares Outstanding | 579.7M | 579.6M | 579.6M | 579.6M | 579.6M |
| Diluted Shares Outstanding | 579.7M | 579.6M | 579.6M | 579.6M | 579.6M |
| Profitability Metrics | |||||
| EBITDA | — | 359.2M | 213.8M | 262.2M | 293.6M |
| D&A | — | 45.3M | 49.0M | 48.0M | 50.9M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026